These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

581 related items for PubMed ID: 26132312

  • 21. Recent pharmacological developments in the treatment of perennial and persistent allergic rhinitis.
    Klimek L, Mullol J, Hellings P, Gevaert P, Mösges R, Fokkens W.
    Expert Opin Pharmacother; 2016; 17(5):657-69. PubMed ID: 26800187
    [Abstract] [Full Text] [Related]

  • 22. Advances in pharmacotherapy for the treatment of allergic rhinitis; MP29-02 (a novel formulation of azelastine hydrochloride and fluticasone propionate in an advanced delivery system) fills the gaps.
    Bousquet J, Bachert C, Bernstein J, Canonica GW, Carr W, Dahl R, Demoly P, Devillier P, Hellings P, Fokkens W, Klimek L, Lieberman P, Meltzer E, Price D, Ryan D, Wahn U.
    Expert Opin Pharmacother; 2015 Apr; 16(6):913-28. PubMed ID: 25747125
    [Abstract] [Full Text] [Related]

  • 23. Bioavailability and disposition of azelastine and fluticasone propionate when delivered by MP29-02, a novel aqueous nasal spray.
    Derendorf H, Munzel U, Petzold U, Maus J, Mascher H, Hermann R, Bousquet J.
    Br J Clin Pharmacol; 2012 Jul; 74(1):125-33. PubMed ID: 22356350
    [Abstract] [Full Text] [Related]

  • 24. MP-AzeFlu is more effective than fluticasone propionate for the treatment of allergic rhinitis in children.
    Berger W, Bousquet J, Fox AT, Just J, Muraro A, Nieto A, Valovirta E, Wickman M, Wahn U.
    Allergy; 2016 Aug; 71(8):1219-22. PubMed ID: 27043452
    [Abstract] [Full Text] [Related]

  • 25. Evaluation of Intranasal Corticosteroid Sensory Attributes and Patient Preference for Fluticasone Furoate for the Treatment of Allergic Rhinitis.
    May JR, Dolen WK.
    Clin Ther; 2019 Aug; 41(8):1589-1596. PubMed ID: 31402060
    [Abstract] [Full Text] [Related]

  • 26. Comparison of intranasal azelastine to intranasal fluticasone propionate for symptom control in moderate-to-severe seasonal allergic rhinitis.
    Carr WW, Ratner P, Munzel U, Murray R, Price D, Canonica GW, Mullol J, Virchow JC, Lieberman P, Meltzer E, Bachert C.
    Allergy Asthma Proc; 2012 Aug; 33(6):450-8. PubMed ID: 23127291
    [Abstract] [Full Text] [Related]

  • 27. Safety evaluation of MP29-02 (a novel intranasal formulation of azelastine hydrochloride and fluticasone propionate) for allergic rhinitis.
    Klimek L, Bousquet J, Price D.
    Expert Opin Drug Saf; 2016 Jan; 15(1):117-29. PubMed ID: 26581312
    [Abstract] [Full Text] [Related]

  • 28. Preferences of adult patients with allergic rhinitis for the sensory attributes of fluticasone furoate versus fluticasone propionate nasal sprays: a randomized, multicenter, double-blind, single-dose, crossover study.
    Meltzer EO, Stahlman JE, Leflein J, Meltzer S, Lim J, Dalal AA, Prillaman BA, Philpot EE.
    Clin Ther; 2008 Feb; 30(2):271-9. PubMed ID: 18343265
    [Abstract] [Full Text] [Related]

  • 29. Intranasal antihistamine is superior to oral H1 antihistamine as an add-on therapy to intranasal corticosteroid for treating allergic rhinitis.
    Du K, Qing H, Zheng M, Wang X, Zhang L.
    Ann Allergy Asthma Immunol; 2020 Nov; 125(5):589-596.e3. PubMed ID: 32650045
    [Abstract] [Full Text] [Related]

  • 30. The Use of Azelastine Hydrochloride/Fluticasone Propionate in the Management of Allergic Rhinitis in Asia: A Review.
    Tantilipikorn P, Kirtsreesakul V, Bunnag C, Vangveeravong M, Thanaviratananich S, Chusakul S.
    J Asthma Allergy; 2024 Nov; 17():667-679. PubMed ID: 39045291
    [Abstract] [Full Text] [Related]

  • 31. A review of the clinical efficacy and safety of MP-AzeFlu, a novel intranasal formulation of azelastine hydrochloride and fluticasone propionate, in clinical studies conducted during different allergy seasons in the US.
    Prenner BM.
    J Asthma Allergy; 2016 Nov; 9():135-43. PubMed ID: 27468241
    [Abstract] [Full Text] [Related]

  • 32. A Clinical Study to Assess the Efficacy and Safety of MP-AzeFlu Nasal Spray in Comparison to Commercially Available Azelastine Hydrochloride and Fluticasone Propionate Nasal Sprays in Chinese Volunteers with Allergic Rhinitis.
    Zhou B, Cheng L, Pan J, Wang H, Jin Y, Zhao C, Lin P, Tan G, Fang H, Zhang H, Zhou H, Dong Y, Kuhl HC, Ramalingam RK, Nguyen DT.
    Pulm Ther; 2023 Sep; 9(3):411-427. PubMed ID: 37580498
    [Abstract] [Full Text] [Related]

  • 33. Azelastine hydrochloride: a review of pharmacology, pharmacokinetics, clinical efficacy and tolerability.
    Bernstein JA.
    Curr Med Res Opin; 2007 Oct; 23(10):2441-52. PubMed ID: 17723160
    [Abstract] [Full Text] [Related]

  • 34. Triamcinolone Acetonide versus Fluticasone Propionate in the Treatment of Perennial Allergic Rhinitis: A Randomized, Parallel-Group Trial.
    Karaulov AV, Vylegzhanina T, Ovchinnikov A, Chernikova M, Nenasheva N.
    Int Arch Allergy Immunol; 2019 Oct; 179(2):142-151. PubMed ID: 30879006
    [Abstract] [Full Text] [Related]

  • 35. Double-blind, placebo-controlled study of azelastine and fluticasone in a single nasal spray delivery device.
    Hampel FC, Ratner PH, Van Bavel J, Amar NJ, Daftary P, Wheeler W, Sacks H.
    Ann Allergy Asthma Immunol; 2010 Aug; 105(2):168-73. PubMed ID: 20674829
    [Abstract] [Full Text] [Related]

  • 36. Azelastine and olopatadine in the treatment of allergic rhinitis.
    Kaliner MA.
    Ann Allergy Asthma Immunol; 2009 Nov; 103(5):373-80. PubMed ID: 19927534
    [Abstract] [Full Text] [Related]

  • 37. Effects of H1 antihistamine addition to intranasal corticosteroid for allergic rhinitis: a systematic review and meta-analysis.
    Seresirikachorn K, Chitsuthipakorn W, Kanjanawasee D, Khattiyawittayakun L, Snidvongs K.
    Int Forum Allergy Rhinol; 2018 Oct; 8(10):1083-1092. PubMed ID: 29917324
    [Abstract] [Full Text] [Related]

  • 38. Safety of a novel intranasal formulation of azelastine hydrochloride and fluticasone propionate in children: A randomized clinical trial.
    Berger W, Sher E, Gawchik S, Fineman S.
    Allergy Asthma Proc; 2018 Mar 01; 39(2):110-116. PubMed ID: 29490769
    [Abstract] [Full Text] [Related]

  • 39. Impact of intranasal corticosteroids on asthma outcomes in allergic rhinitis: a meta-analysis.
    Lohia S, Schlosser RJ, Soler ZM.
    Allergy; 2013 Mar 01; 68(5):569-79. PubMed ID: 23590215
    [Abstract] [Full Text] [Related]

  • 40. Fluticasone furoate: a new intranasal corticosteroid.
    Kumar R, Kumar D, Parakh A.
    J Postgrad Med; 2012 Mar 01; 58(1):79-83. PubMed ID: 22387656
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 30.